[{"Assets_0_Q2_USD":501456000.0,"CommonStockSharesOutstanding_0_Q2_shares":38551426.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-72950000.0,"NetIncomeLoss_1_Q2_USD":-45695000.0,"NetIncomeLoss_2_Q2_USD":-86607000.0,"StockholdersEquity_0_Q2_USD":472481000.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]